Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 166 Thousand HKD | -99.73% |
| 2022 | 60.73 Million HKD | -19.32% |
| 2021 | 75.27 Million HKD | 15.54% |
| 2020 | 65.14 Million HKD | 8.17% |
| 2019 | 60.22 Million HKD | 5619.66% |
| 2018 | 1.05 Million HKD | 74.05% |
| 2017 | 605 Thousand HKD | 8.81% |
| 2016 | 556 Thousand HKD | -0.89% |
| 2015 | 561 Thousand HKD | 0.0% |
| 2014 | - HKD | 0.0% |
| 2013 | - HKD | 0.0% |
| 2012 | - HKD | 0.0% |
| 2011 | - HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 83 Thousand HKD | 0.0% |
| 2024 Q1 | 83 Thousand HKD | -50.0% |
| 2023 Q2 | 76.5 Million HKD | 0.0% |
| 2023 FY | 166 Thousand HKD | -99.73% |
| 2023 Q1 | 76.5 Million HKD | 25.97% |
| 2023 Q4 | 166 Thousand HKD | -99.78% |
| 2023 Q3 | 75.39 Million HKD | -1.45% |
| 2022 Q1 | 62.18 Million HKD | -17.38% |
| 2022 FY | 60.73 Million HKD | -19.32% |
| 2022 Q4 | 60.73 Million HKD | 0.0% |
| 2022 Q3 | 60.73 Million HKD | -2.34% |
| 2022 Q2 | 62.18 Million HKD | 0.0% |
| 2021 Q1 | 75.6 Million HKD | 16.05% |
| 2021 FY | 75.27 Million HKD | 15.54% |
| 2021 Q3 | 75.27 Million HKD | -0.44% |
| 2021 Q4 | 75.27 Million HKD | 0.0% |
| 2021 Q2 | 75.6 Million HKD | 0.0% |
| 2020 Q3 | 65.14 Million HKD | 5.31% |
| 2020 FY | 65.14 Million HKD | 8.17% |
| 2020 Q1 | 61.86 Million HKD | 2.72% |
| 2020 Q2 | 61.86 Million HKD | 0.0% |
| 2020 Q4 | 65.14 Million HKD | 0.0% |
| 2019 Q4 | 60.22 Million HKD | 0.0% |
| 2019 Q2 | 68.37 Million HKD | 0.0% |
| 2019 FY | 60.22 Million HKD | 5619.66% |
| 2019 Q3 | 60.22 Million HKD | -11.91% |
| 2019 Q1 | 68.37 Million HKD | 6393.07% |
| 2018 FY | 1.05 Million HKD | 74.05% |
| 2018 Q4 | 1.05 Million HKD | 0.0% |
| 2018 Q3 | 1.05 Million HKD | -7.55% |
| 2018 Q2 | 1.13 Million HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2017 Q2 | 596 Thousand HKD | 0.0% |
| 2017 FY | 605 Thousand HKD | 8.81% |
| 2017 Q4 | 605 Thousand HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 Q3 | - HKD | -100.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 FY | 556 Thousand HKD | -0.89% |
| 2016 Q4 | 556 Thousand HKD | 0.0% |
| 2016 Q2 | 575 Thousand HKD | 0.0% |
| 2015 Q4 | 561 Thousand HKD | 0.0% |
| 2015 Q2 | 4.31 Million HKD | 0.0% |
| 2015 FY | 561 Thousand HKD | 0.0% |
| 2015 Q1 | - HKD | 0.0% |
| 2014 FY | - HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 Q2 | - HKD | 0.0% |
| 2014 Q1 | - HKD | 0.0% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q2 | - HKD | 0.0% |
| 2013 Q1 | - HKD | 0.0% |
| 2013 FY | - HKD | 0.0% |
| 2012 Q4 | - HKD | 0.0% |
| 2012 FY | - HKD | 0.0% |
| 2011 FY | - HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| China Healthwise Holdings Limited | 2.14 Million HKD | 92.275% |
| Tycoon Group Holdings Limited | 8.89 Million HKD | 98.134% |